Following food intake, GLP-1 is released into the bloodstream, where it stimulates glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon release from alpha cells, and slows gastric emptying
1, 2 Diet and life-style modification represent the first-line treatment in the management of obesity, but as these often fail to provide sustainable weight loss, pharmaceutical intervention may be necessary for the achievement of long-term, clinically relevant weight loss
It gives a general figure for pens but treats the dispensing pharmacy as authoritative
IP assets that may be licensed or sold separately a new indications method-of-use portfolio, a device patent family, a manufacturing process patent are harder to transact when embedded in a CIP family that is legally entangled with the parent through shared prosecution history, terminal disclaimers, and dual priority date dependencies